Drugs / NSC 748933
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00857545 | Jul 2010 → Sep 2015 | fallopian tube cancer, ovarian carcinoma, primary peritoneal carcinoma | Gynecologic Oncology Group | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NSC 748933 | “A phase II randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian, fallopian...” PMID 31653510 ↗ Oct 2019 |
| Modality | Vaccine | “polyvalent vaccine” NCT00857545 ↗ |
| Route | Subcutaneous | “Given SC” NCT00857545 ↗ |